Immunity drives TET1 regulation in cancer through NF-κB
Abstract A new paradigm has emerged showing that the immune system can influence cancer cell epigenetics through NF-κB–mediated regulation of TET1. Authors: Evelyne Collignon ⚬, Annalisa Canale, Clémence Al Wardi ⚬, Martin Bizet, Emilie Calonne ⚬, Sarah Dedeurwaerder, Soizic Garaud, Céline Naveaux, Whitney Barham, Andrew Wilson, Sophie Bouchat, Pascale Hubert ⚬, Carine Van Lint, Fiona Yull, Christos Sotiriou, Karen Willard-Gallo ⚬, Agnès Noel, François Fuks Affiliations: Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB (Université libre de Bruxelles)–Cancer Research Center
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in